Bridgeway Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bridgeway Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$170K	Sell	26,200 -137,268	-84%	-$658K	﹤0.01%	1090
2026 Q1	$531K	Hold	163,468	–	–	0.01%	817
2025 Q4	$651K	Sell	163,468 -24,887	-13%	-$73.8K	0.01%	774
2025 Q3	$588K	Hold	188,355	–	–	0.01%	772
2025 Q2	$631K	Buy	188,355 +4,200	+2%	+$19.9K	0.02%	733
2025 Q1	$779K	Hold	184,155	–	–	0.02%	678
2024 Q4	$436K	Sell	184,155 -102,500	-36%	-$151K	0.01%	845
2024 Q3	$367K	Hold	286,655	–	–	0.01%	928
2024 Q2	$439K	Hold	286,655	–	–	0.01%	888
2024 Q1	$482K	Hold	286,655	–	–	0.01%	943
2023 Q4	$499K	Hold	286,655	–	–	0.01%	946
2023 Q3	$542K	Hold	286,655	–	–	0.01%	852
2023 Q2	$421K	Hold	286,655	–	–	0.01%	955
2023 Q1	$559K	Hold	286,655	–	–	0.01%	858
2022 Q4	$645K	Hold	286,655	–	–	0.02%	835
2022 Q3	$691K	Hold	286,655	–	–	0.02%	817
2022 Q2	$595K	Hold	286,655	–	–	0.01%	841
2022 Q1	$808K	Buy	286,655 +50,400	+21%	+$168K	0.02%	828
2021 Q4	$1.1M	Buy	236,255 +75,268	+47%	+$257K	0.02%	772
2021 Q3	$435K	Buy	160,987 +7,600	+5%	+$22.6K	0.01%	1075
2021 Q2	$436K	Sell	153,387 -2,800	-2%	-$8.24K	0.01%	1109
2021 Q1	$473K	Buy	156,187 +4,900	+3%	+$15.9K	0.01%	1099
2020 Q4	$445K	Sell	151,287 -31,713	-17%	-$96K	0.01%	987
2020 Q3	$587K	Hold	183,000	–	–	0.01%	832
2020 Q2	$609K	Hold	183,000	–	–	0.01%	799
2020 Q1	$664K	Hold	183,000	–	–	0.02%	665
2019 Q4	$942K	Hold	183,000	–	–	0.01%	751
2019 Q3	$1.08M	Hold	183,000	–	–	0.02%	702
2019 Q2	$1.17M	Sell	183,000 -17,400	-9%	-$106K	0.01%	680
2019 Q1	$1.16M	Hold	200,400	–	–	0.01%	705
2018 Q4	$1.26M	Sell	200,400 -5,000	-2%	-$29.9K	0.02%	645
2018 Q3	$1.17M	Hold	205,400	–	–	0.01%	816
2018 Q2	$1.26M	Sell	205,400 -78,300	-28%	-$490K	0.01%	785
2018 Q1	$1.9M	Hold	283,700	–	–	0.02%	610
2017 Q4	$2.1M	Hold	283,700	–	–	0.02%	580
2017 Q3	$2M	Sell	283,700 -10,000	-3%	-$69.2K	0.02%	604
2017 Q2	$2.08M	Hold	293,700	–	–	0.03%	574
2017 Q1	$2.04M	Buy	293,700 +16,400	+6%	+$99.4K	0.02%	567
2016 Q4	$1.52M	Hold	277,300	–	–	0.02%	654
2016 Q3	$1.39M	Hold	277,300	–	–	0.02%	669
2016 Q2	$1.25M	Hold	277,300	–	–	0.02%	696
2016 Q1	$1.25M	Buy	277,300 +150,000	+118%	+$715K	0.02%	676
2015 Q4	$670K	Buy	127,300 +43,300	+52%	+$247K	0.01%	939
2015 Q3	$485K	Hold	84,000	–	–	0.01%	1044
2015 Q2	$601K	Hold	84,000	–	–	0.01%	983
2015 Q1	$559K	Hold	84,000	–	–	0.01%	1048
2014 Q4	$504K	Hold	84,000	–	–	0.01%	1058
2014 Q3	$415K	Hold	84,000	–	–	0.01%	1167
2014 Q2	$378K	Hold	84,000	–	–	0.01%	1201
2014 Q1	$378K	Hold	84,000	–	–	0.01%	1190
2013 Q4	$429K	Hold	84,000	–	–	0.01%	1111
2013 Q3	$381K	Buy	84,000 +67,500	+409%	+$336K	0.01%	1148
2013 Q2	$84K	Buy	+16,500	New	+$82.1K	﹤0.01%	1354

Other funds holding CPIX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Bridgeway Capital Management's CPIX Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Cumberland Pharmaceuticals (CPIX) stake by 84% in Q2 2026, selling an estimated $658K and leaving 26,200 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Bridgeway Capital Management first reported a position in CPIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.1M in Q4 2017. 21 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

Bridgeway Capital Management held 26,200 shares of Cumberland Pharmaceuticals worth $170K as of Q2 2026.
Bridgeway Capital Management sold 137,268 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $658K.
Cumberland Pharmaceuticals made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1090 holding.
Bridgeway Capital Management first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
Bridgeway Capital Management's Cumberland Pharmaceuticals position peaked at $2.1M in Q4 2017.
21 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.